100-year anniversary of Boehringer Ingelheim in respiratory care

In 1921, Boehringer Ingelheim set out with a vision to transform the world of respiratory care. Now, in 2021 marks the company looks back on 100 years of pushing the boundaries in scientific innovation and research to create ground-breaking solutions across a range of respiratory conditions.

Over the past 100 years, Boehringer Ingelheim has emerged as a leader in this therapy area, having launched several treatments in a range of respiratory conditions including chronic obstructive pulmonary disease (COPD), asthma, and pulmonary fibrosis. The focus has always been to improve the quality of life for patients suffering from debilitating respiratory diseases and enable them to maintain a more independent lifestyle.

Find out more about the respiratory disease area